Olema Pharmaceuticals, Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Dec 2018 | — | $-8.4M | $3.1M |
| Dec 2019 | — | $-10.6M | $68.0K |
| Mar 2020 | — | $-11.7M | $27.9M |
| Jun 2020 | — | $-14.0M | $50.5M |
| Sep 2020 | — | $-23.0M | $127.8M |
| Dec 2020 | — | $338.1M | $338.5M |
| Mar 2021 | — | $326.0M | $47.9M |
| Jun 2021 | — | $314.1M | $50.4M |
| Sep 2021 | — | $300.9M | $25.6M |
| Dec 2021 | — | $284.6M | $13.8M |
| Mar 2022 | — | $265.1M | $21.5M |
| Jun 2022 | — | $236.3M | $24.5M |
| Sep 2022 | — | $217.7M | $26.8M |
| Dec 2022 | — | $197.5M | $23.7M |
| Mar 2023 | — | $175.0M | $40.9M |
| Jun 2023 | — | $161.6M | $35.0M |
| Sep 2023 | — | $275.1M | $117.4M |
| Dec 2023 | — | $253.9M | $68.5M |
| Mar 2024 | — | $236.3M | $33.7M |
| Jun 2024 | — | $227.2M | $16.9M |
| Sep 2024 | — | $198.9M | $35.9M |
| Dec 2024 | — | $409.0M | $139.5M |
| Mar 2025 | — | $383.5M | $50.6M |
| Jun 2025 | — | $345.2M | $52.5M |
| Sep 2025 | — | $307.5M | $35.3M |
| Dec 2025 | — | $478.6M | $48.3M |
| Mar 2026 | — | $480.5M | $52.5M |
| Jun 2026 | — | $430.6M | $48.6M |